TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Occurrence of moderate and severe AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Brigatinib plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction with chronic illness care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Movement Disorder Society Unified Parkinson's Disease Rating Scale testing of motor function, Part III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pSN free-water accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge score on hypertension
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Predictive performance of integrated model A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total-FGF23 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neonatal intact-FGF23 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maternal hepcidin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower number of tablets prescribed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower morphine milligram equivalents (MME) prescribed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of intrauterine adhesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall pregnancy rate at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Affective aspects improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Behavioral aspects improvement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: NSAA scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6MWT distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: BDI‐II score improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SF‐36 and HeartQoL values improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cumulative incidence of varicella infection or shingles
Endpoint domain: Adverse events/effects
Primary endpoint: Mean increases in geometric mean fold rise as measured by gpELISA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean increases in geometric mean fold rise as measured by ELISpot
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean change in HBV RNA from baseline to Day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of additional analgesics administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total analgesic use in the postoperative period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of patients achieving ≥5% weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of ticagrelor versus prasugrel
Endpoint domain: Mortality/survival
Primary endpoint: Bleeding Academic Research Consortium types 3 to 5 bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Teachers' perception of school meals as healthy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 3-month composite of death or RV/LV greater than 0.9
Endpoint domain: Mortality/survival
Primary endpoint: 3-month RV/LV ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase in intention to accept IRS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increase in actual acceptance of IRS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: VISA-A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rates of postpartum hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Mothers' breastfeeding practice
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Facial attractiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial unattractiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluated BMI based on facial assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of responders (50% improvement in pain scores)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infective endocarditis rate at 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of patients requiring sufentanil
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Epithelialization on day 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mAlb/Cr
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: mean AABP magnitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Meibomian Gland Yielding Secretion Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTG
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CARE Measure scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of Recovery (QoR)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Retention of visual acuity of 20/200 or better
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of 10 or more ETDRS letters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for VP shunt insertion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cognitive outcome at 2 years
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of major depressive episode by 12 months postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Work Ability Index scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: myoFSR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation in HR and MBP from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: First ETCO2 after intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Participation in CDSMP
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Sleep dysfunction measurement
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Cognitive worsening (SDMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 9HPT worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fatigue measured with the Tiredness question (Q11)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Median survival time to cure
Endpoint domain: Mortality/survival
Primary endpoint: Time to recovery
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of breastfeeding problems
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: 2-year local tumor progression (LTP) rates
Endpoint domain: Mortality/survival
Primary endpoint: 2-year LTP-free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: 2-year recurrence-free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: longer sleep duration in late pregnancy
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: higher breastfeeding rates on discharge
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: lower triglyceride levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Axial length augmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale (VAS) for tinnitus annoyance and intensity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Consent rate for SPIN-SELF Program
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Usage frequency of SPIN-SELF Program
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Improvements in quality of life (QoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mean net iAUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: peak blood glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total heart failure hospitalisations and cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: improvement in metabolic blood profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Chemical castration rate at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in endometriosis-associated pelvic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in serum concentrations of E2, luteinizing hormone, and follicle-stimulating hormone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: severely elevated liver fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of meat taken by patrons
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Washin time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Washout time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Image quality scoring for OCT vs IVUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular disease (CVD) event burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: feeding duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: volume or percentage of food taken
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3D-LVEF decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Global longitudinal strain (GLS) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: NRS reduction in pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DLPFC plasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: LDL aggregation susceptibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increased sensitivity of fathers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increased involvement with the infant
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: level of women's pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: defecation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Activation of TrA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: NSS (Neuropathy Symptom Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: NDS (Neuropathy Disability Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: perioperative total blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hb drop at postoperative days 1, 3 and 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Response to acupuncture for hot flashes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: timely event notification of non-VHA emergency department visits and hospital admissions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-discharge follow-up
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Incidence of postoperative neurocognitive disorders
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of time within the BIS target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative propofol consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight gain at the end of pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood glucose monitoring compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: fewer antibiotic prescriptions for respiratory infection
Endpoint domain: Adverse events/effects
Primary endpoint: less oxygen therapy requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Death from any cause or ESKD
Endpoint domain: Mortality/survival
Primary endpoint: Breastfeeding education and support
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Child ZBMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LnSDNN
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LnHfa power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Brimacombe fibreoptic visualisation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of requirement of optimisation
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of visceral traction pain
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative consumptions of fentanyl and ketorolac
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corticosteroid-binding globulin (CBG) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: sexual functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: self‐rating anxiety scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self‐rating depression scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: deep venous thrombosis incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative incidence of chronic low back pain
Endpoint domain: Adverse events/effects
Primary endpoint: Multifidus muscle atrophy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Total adverse events (TEAEs) leading to discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of new-onset diabetes/hyperglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of gout
Endpoint domain: Adverse events/effects
Primary endpoint: PUTS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SUDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eradication of Pseudomonas aeruginosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Apgar scores at five minutes of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Life impact of urinary incontinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: IIQ scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fecal Fusicatenibacter saccharivorans levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Akkermansia muciniphila levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Faecalibacterium prausnitzii levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: shuttle run test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Limb blood flow change rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 800-m running performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: first CV events
Endpoint domain: Mortality/survival
Primary endpoint: Time required for complete recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to accept follow‐up colonoscopy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Discomfort symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: theoretical and skill exam scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: opioid consumption in the first 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of MMP‐1, MMP‐2, and MMP‐9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-year locoregional control (LRC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attitudes towards dementia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: duration of antibiotics need
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: days for clinical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interest in IR
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: knowledge of IR
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: likelihood of choosing IR as a subspecialty
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Favorable outcome of FN episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in tongue fat tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in fat proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probiotic potential of Lactobacillus strains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of pathogenic bacteria growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibiotic susceptibility
Endpoint domain: Adverse events/effects
Primary endpoint: intraocular pressure > 25 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: corneal edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: retinal detachment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Improvement in Covid related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Sp02 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Association between migraine and large-artery atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Labial alveolar bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crown edge drift
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RCFT copy task total score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: moderate-to-vigorous physical activity minutes/day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T-SOD improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in serum IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in urine 8-iso-PGF2α
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to definitive 10% deterioration in EORTC Global Health Status scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to definitive 10% deterioration in FACT-C functional well-being subscale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: MRSS (Modified Rodnan Skin Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Back and trunk flexion endurance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: efficiency of government expenditure on public dental services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: provision of person-centred courses of dental care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: utilisation of university dental education programs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Vividness of memories
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WMH progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Time to starting docetaxel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes